نتایج جستجو برای: platelet aggregation inhibitorsadverse effects

تعداد نتایج: 1687119  

Journal: :Acta poloniae pharmaceutica 2012
M Zia-ul-Haq Barkat Ali Khan Premysl Landa Zsófia Kutil Sagheer Ahmed Mughal Qayum Shakeel Ahmad

Inflammation is the natural body defense mechanism for the removal of injurious agents, necrosed cells and tissues from the body. This study was aimed to evaluate the anti-inflammatory and platelet aggregation effects of three medicinal plants of Pakistan. Methanolic extract of garden pea inhibited arachidonic acid (AA)-induced platelet aggregation (IC50 = 35 microg/mL) and platelet activating ...

Journal: :Stroke 1994
T Komiya M Kudo T Urabe Y Mizuno

BACKGROUND AND PURPOSE Antiplatelet therapy is currently one of the methods for preventing transient ischemic attacks and cerebral thrombosis. Because antiplatelet agents are generally administered on a long-term basis, patient compliance is an important factor. The purpose of this study was to determine the compliance of patients during antiplatelet therapy by testing platelet aggregation. M...

Journal: :Cancer research 1986
P Mehta D Lawson M B Ward L Lee-Ambrose A Kimura

There is evidence that tumors may stimulate platelet aggregation, causing release of thromboxane A2. Thromboxane A2 may potentiate tumor metastasis by stimulating tumor cell growth and proliferation and by enhancing platelet-tumor cell aggregate formation. Despite potential significance of thromboxane A2 in tumor metastasis, agents which inhibit thromboxane A2 synthesis have not been uniformly ...

Background: Cinnamon belongs to the Lauraceae family and is one of the most common spices that are used as traditional medicine in the world. The bark and leaf of cinnamon contain essential oils and derivatives including cinnamaldehyde, cinnamic acid and several other compounds such as polyphenols. Moreover, anti-inflammatory and lipid lowering properties of cinnamon has been proven. Objective:...

Journal: :Clinical science 2012
Alexander O Spiel Ulla Derhaschnig Michael Schwameis Johann Bartko Jolanta M Siller-Matula Bernd Jilma

P2Y(12) receptor antagonists have become a mainstay for the treatment of CVD (cardiovascular diseases). However, they have rarely been evaluated under pathophysiological conditions apart from arterial diseases. We hypothesized interactions between prasugrel and enhanced vWF (von Willebrand Factor) release in a model of systemic inflammation, and compared the pharmacodynamic effects of prasugrel...

Journal: :Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2010
Angelika Schedel Sophia Thornton Harald Klüter Peter Bugert

BACKGROUND: Neuro-hormonal and hemostatic mechanisms are important in a wide range of psychological and cardiovascular diseases. The use of psychoactive drugs in mental illnesses is often involved with hematologic side effects including impaired platelet function. Subsequently, the risk for the development of cardiovascular diseases may be higher in these patients. Interestingly, platelets that...

Journal: :Indian journal of biochemistry & biophysics 2013
Ioannis K Toliopoulos Yannis V Simos Stergios Oikonomidis Spyros C Karkabounas

Platelet aggregation around migrating cancer cells protects them against the activity of natural killer cells (NKCs). The inability of immune system to response results in the progression of malignant diseases. This study was designed to evaluate the effects of resveratrol (3, 4', 5-trihydroxystilbene) on platelet aggregation and NKCs activity. Experiments were designed to evaluate the platelet...

2015
Diana A. Gorog

General Considerations D espite the essential role of platelets in arterial thrombogenesis, personalized antiplatelet therapy based on platelet function tests (PFTs) did not improve clinical outcome after coronary revascularization and did not predict recurrent ischemic or bleeding events in individual patients. To understand why these point-of-care PFTs have yielded so little clinical benefit,...

2016
Dursun Gündüz Christian Tanislav Daniel Sedding Mariana Parahuleva Sentot Santoso Christian Troidl Christian Hamm Muhammad Aslam

Platelet P2Y12 is an important ADP receptor that is involved in agonists-induced platelet aggregation and is an important target for the development of anti-platelet aggregation drugs. Here the effects of thio-analogues of uridine triphosphate (UTP) on ADP-induced platelet aggregation are characterised. Using human platelet rich plasma we demonstrate that UTP inhibits P2Y12 but not P2Y1 recepto...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید